Schlicker, A. (author), Beran, G. (author), Chresta, C.M. (author), McWalter, G. (author), Pritchard, A. (author), Weston, S. (author), Runswick, S. (author), Davenport, S. (author), Heathcote, K. (author), Alferez Castro, D. (author), Orphanides, G. (author), French, T. (author), Wessels, L.F.A. (author) Background Colorectal cancer (CRC) is a heterogeneous and biologically poorly understood disease. To tailor CRC treatment, it is essential to first model this heterogeneity by defining subtypes of patients with homogeneous biological and clinical characteristics and second match these subtypes to cell lines for which extensive pharmacological...
journal article 2012
